Task: Answer the multiple-choice question.
Question: Which drug exhibits a -10.304% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a: CC1CCN(C(=O)CSc2nnc(Cn3c(=O)sc4ccccc43)n2C)CC1
b: Cc1nc(NC(=O)c2ccc(Br)s2)sc1C(=O)N(C)C
c: O=C(c1cccs1)n1nc(-c2ccc(Cl)cc2)nc1NCc1ccco1
d: COCCNc1nnc(SCC(=O)Nc2sc3c(c2C(=O)c2ccccc2)CCCC3)s1
e: CCC(=O)N1CCc2cc(S(=O)(=O)N(CC)c3cccc(C)c3)ccc21
Answer: a. CC1CCN(C(=O)CSc2nnc(Cn3c(=O)sc4ccccc43)n2C)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CCN(C(=O)CSc2nnc(Cn3c(=O)sc4ccccc43)n2C)CC1
CC1CCN(C(=O)CSc2nnc(Cn3c(=O)sc4ccccc43)n2C)CC1
3-[[4-methyl-5-[2-(4-methylpiperidin-1-yl)-2-oxoethyl]sulfanyl-1,2,4-triazol-3-yl]methyl]-1,3-benzothiazol-2-one